DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Phosphatidylinositol signaling system	R-HSA-1280215	map04070	vigabatrin	5665	drug-path
Renal cell carcinoma	R-HSA-9794523	map05211	vigabatrin	5665	drug-path
Olfactory transduction	R-HSA-9751605	map04740	vigabatrin	5665	drug-path
Chronic myeloid leukemia	R-HSA-9680350	map05220	vigabatrin	5665	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	vigabatrin	5665	drug-path
Gap junction	R-HSA-190861	map04540	vigabatrin	5665	drug-path
Focal adhesion	R-HSA-354113	map04510	nocodazole	5280961	drug-path
Circadian rhythm - mammal	R-HSA-400253	0	nocodazole	5280961	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	nocodazole	5280961	drug-path
Hematopoietic cell lineage	R-HSA-173752	map04640	nocodazole	5280961	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	nocodazole	5280961	drug-path
Olfactory transduction	R-HSA-9751605	map04740	nocodazole	5280961	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	nocodazole	5280961	drug-path
Pancreatic cancer	R-HSA-9700206	map05212	nocodazole	5280961	drug-path
Cell cycle	R-HSA-1640170	map04110	nocodazole	5280961	drug-path
Prostate cancer	R-HSA-2990872	map05215	nocodazole	5280961	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	nocodazole	5280961	drug-path
Endometrial cancer	R-HSA-2077421	map05213	nocodazole	5280961	drug-path
Pancreatic cancer	R-HSA-9700206	map05212	5666823	None	drug-path
Prostate cancer	R-HSA-2990872	map05215	5666823	None	drug-path